耐药机制-话题@MedSci

#耐药机制#

32篇内容 | 1629人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1971353, encodeId=07b819e135356, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=CLIN CANCER RES：非小细胞肺癌患者Osimertinib耐药机制, objectType=article, longId=142571, objectId=bb831425e113, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb831425e113, replyNumber=0, likeNumber=81, createdTime=2019-02-01, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb831425e113, moduleTitle=CLIN CANCER RES：非小细胞肺癌患者Osimertinib耐药机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb831425e113)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971351, encodeId=09b619e1351ee, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=Cancer Cell：肿瘤细胞生长耐药机制获揭示, objectType=article, longId=119578, objectId=c28f1195e817, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c28f1195e817, replyNumber=0, likeNumber=91, createdTime=2018-01-02, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c28f1195e817, moduleTitle=Cancer Cell：肿瘤细胞生长耐药机制获揭示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c28f1195e817)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971352, encodeId=9e5819e135241, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=Nat Commun：黑色素瘤耐药机制研究取得突破性进展, objectType=article, longId=132062, objectId=19f613206219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19f613206219, replyNumber=0, likeNumber=76, createdTime=2018-03-28, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19f613206219, moduleTitle=Nat Commun：黑色素瘤耐药机制研究取得突破性进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19f613206219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971349, encodeId=83f419e134988, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=CLIN CANCER RES：HER2+乳腺癌HER2靶向治疗耐药机制, objectType=article, longId=112660, objectId=f87a112660d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f87a112660d1, replyNumber=0, likeNumber=76, createdTime=2018-07-06, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f87a112660d1, moduleTitle=CLIN CANCER RES：HER2+乳腺癌HER2靶向治疗耐药机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f87a112660d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971350, encodeId=b44619e1350fd, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=CLIN CANCER RES：FGFR1过表达肺癌原发耐药机制, objectType=article, longId=113919, objectId=e159113919ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e159113919ed, replyNumber=0, likeNumber=78, createdTime=2017-10-26, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e159113919ed, moduleTitle=CLIN CANCER RES：FGFR1过表达肺癌原发耐药机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e159113919ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971348, encodeId=eaf019e1348d8, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=Curr Oncol：肺癌耐药机制及临床诊疗策略制定, objectType=article, longId=99527, objectId=db379952e67, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db379952e67, replyNumber=0, likeNumber=60, createdTime=2018-01-12, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db379952e67, moduleTitle=Curr Oncol：肺癌耐药机制及临床诊疗策略制定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db379952e67)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971347, encodeId=ff8719e13471d, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=Cancer Res：清华大学郭伟课题组揭示临床肺肿瘤干细胞的自我更新与耐药机制, objectType=article, longId=97235, objectId=fef69e23586, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fef69e23586, replyNumber=0, likeNumber=66, createdTime=2017-10-31, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fef69e23586, moduleTitle=Cancer Res：清华大学郭伟课题组揭示临床肺肿瘤干细胞的自我更新与耐药机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fef69e23586)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971346, encodeId=cdba19e13468a, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=Cell：大规模乳腺癌功能基因组学研究结果发布，揭示肿瘤异质性，易感性和耐药机制, objectType=article, longId=62199, objectId=69b3621993c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69b3621993c, replyNumber=0, likeNumber=87, createdTime=2016-02-04, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69b3621993c, moduleTitle=Cell：大规模乳腺癌功能基因组学研究结果发布，揭示肿瘤异质性，易感性和耐药机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69b3621993c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971345, encodeId=702d19e13457a, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=ASCO GU 2015：泌尿生殖系肿瘤免疫靶向药物的疗效和耐药机制, objectType=article, longId=48023, objectId=8254480230b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8254480230b, replyNumber=0, likeNumber=73, createdTime=2015-05-09, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8254480230b, moduleTitle=ASCO GU 2015：泌尿生殖系肿瘤免疫靶向药物的疗效和耐药机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8254480230b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971344, encodeId=55f519e13441d, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=CSMO 2014：徐建明教授谈胃癌的耐药机制和分子分型的探讨, objectType=article, longId=38046, objectId=782038046e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=782038046e8, replyNumber=0, likeNumber=79, createdTime=2014-07-26, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=782038046e8, moduleTitle=CSMO 2014：徐建明教授谈胃癌的耐药机制和分子分型的探讨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=782038046e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971343, encodeId=68af19e13438a, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=CSMO 2014：张国君教授谈乳腺癌内分泌耐药机制, objectType=article, longId=38042, objectId=97003804220, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97003804220, replyNumber=0, likeNumber=68, createdTime=2014-09-02, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97003804220, moduleTitle=CSMO 2014：张国君教授谈乳腺癌内分泌耐药机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97003804220)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971342, encodeId=e1d319e134275, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=Nat Rev Cancer：乳腺癌耐药机制新发现, objectType=article, longId=29515, objectId=3dd42951539, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dd42951539, replyNumber=0, likeNumber=67, createdTime=2014-03-09, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dd42951539, moduleTitle=Nat Rev Cancer：乳腺癌耐药机制新发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3dd42951539)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971341, encodeId=d28d19e134122, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=PLoS One：张清媛等乳腺癌内分泌耐药机制研究获重要成果, objectType=article, longId=28750, objectId=9c2528e5068, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c2528e5068, replyNumber=0, likeNumber=67, createdTime=2014-09-16, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c2528e5068, moduleTitle=PLoS One：张清媛等乳腺癌内分泌耐药机制研究获重要成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c2528e5068)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971340, encodeId=07d319e134048, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=Cell Res：H7N9禽流感病毒耐药机制研究方面取得重要进展, objectType=article, longId=26187, objectId=bbef2618ec0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbef2618ec0, replyNumber=0, likeNumber=74, createdTime=2014-10-18, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbef2618ec0, moduleTitle=Cell Res：H7N9禽流感病毒耐药机制研究方面取得重要进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbef2618ec0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971339, encodeId=bfa919e1339f9, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=JCO：新研究揭示转移性黑色素瘤对威罗菲尼的耐药机制, objectType=article, longId=17544, objectId=2ed31e54498, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ed31e54498, replyNumber=0, likeNumber=72, createdTime=2013-12-11, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ed31e54498, moduleTitle=JCO：新研究揭示转移性黑色素瘤对威罗菲尼的耐药机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ed31e54498)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971337, encodeId=f85819e1337c0, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=PNAS：科学家发现神经母细胞瘤患者的耐药机制, objectType=article, longId=9001, objectId=3ea4900143, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ea4900143, replyNumber=0, likeNumber=55, createdTime=2013-01-24, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ea4900143, moduleTitle=PNAS：科学家发现神经母细胞瘤患者的耐药机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ea4900143)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971338, encodeId=736419e13382a, content=<a href='/topic/show?id=ee288039ece' target=_blank style='color:#2F92EE;'>#耐药机制#</a>, objectTitle=Cancer Res.:揭示卵巢癌获得性耐药机制, objectType=article, longId=9091, objectId=0179909175, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0179909175, replyNumber=0, likeNumber=92, createdTime=2012-09-20, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0179909175, moduleTitle=Cancer Res.:揭示卵巢癌获得性耐药机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0179909175)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

耐药机制

2020-05-29

zhaojie88 (审核中...)

前往app查看评论内容

#耐药机制#

CLIN CANCER RES：非小细胞肺癌患者Osimertinib耐药机制

2019-02-01

zhaojie88 (审核中...)

前往app查看评论内容

#耐药机制#

Cancer Cell：肿瘤细胞生长耐药机制获揭示

2018-01-02

zhaojie88 (审核中...)

前往app查看评论内容

#耐药机制#

Nat Commun：黑色素瘤耐药机制研究取得突破性进展

2018-03-28

zhaozuguo (审核中...)

前往app查看评论内容

#耐药机制#

CLIN CANCER RES：HER2+乳腺癌HER2靶向治疗耐药机制

2018-07-06

zhaojie88 (审核中...)

前往app查看评论内容

#耐药机制#

CLIN CANCER RES：FGFR1过表达肺癌原发耐药机制

2017-10-26

zhaozuguo (审核中...)

前往app查看评论内容

#耐药机制#

Curr Oncol：肺癌耐药机制及临床诊疗策略制定

2018-01-12

zhaozuguo (审核中...)

前往app查看评论内容

#耐药机制#

Cancer Res：清华大学郭伟课题组揭示临床肺肿瘤干细胞的自我更新与耐药机制

2017-10-31

zhaozuguo (审核中...)

前往app查看评论内容

#耐药机制#

Cell：大规模乳腺癌功能基因组学研究结果发布，揭示肿瘤异质性，易感性和耐药机制

2016-02-04

zhaozuguo (审核中...)

前往app查看评论内容

#耐药机制#

ASCO GU 2015：泌尿生殖系肿瘤免疫靶向药物的疗效和耐药机制

2015-05-09

zhaozuguo (审核中...)

前往app查看评论内容

#耐药机制#

CSMO 2014：徐建明教授谈胃癌的耐药机制和分子分型的探讨

2014-07-26

zhaozuguo (审核中...)

前往app查看评论内容

#耐药机制#

CSMO 2014：张国君教授谈乳腺癌内分泌耐药机制

2014-09-02

zhaozuguo (审核中...)

前往app查看评论内容

#耐药机制#

Nat Rev Cancer：乳腺癌耐药机制新发现

2014-03-09

zhaozuguo (审核中...)

前往app查看评论内容

#耐药机制#

PLoS One：张清媛等乳腺癌内分泌耐药机制研究获重要成果

2014-09-16

zhaozuguo (审核中...)

前往app查看评论内容

#耐药机制#

Cell Res：H7N9禽流感病毒耐药机制研究方面取得重要进展

2014-10-18

zhaozuguo (审核中...)

前往app查看评论内容

#耐药机制#

JCO：新研究揭示转移性黑色素瘤对威罗菲尼的耐药机制

2013-12-11

zhaozuguo (审核中...)

前往app查看评论内容

#耐药机制#

PNAS：科学家发现神经母细胞瘤患者的耐药机制

2013-01-24

zhaozuguo (审核中...)

前往app查看评论内容

#耐药机制#

Cancer Res.:揭示卵巢癌获得性耐药机制

2012-09-20

科室
- - 订阅+
  - 更多科室
工具
服务